The expression levels and survival prognosis of SNHG15 in cancers via accessing the GEPIA cohort
cholangiocarcinoma, colonadenocarcinoma, lymphoid neoplasm diffuse large B-cell lymphoma, kidney renal clear cell carcinoma, acute myeloid leukemia (A). pancreatic adenocarcinoma, rectum adenocarcinoma, testicular germ cell tumors, thyroid carcinoma and thymoma were revealed in (B). Survival plots in the GEPIA cohort via merging the expression data of SNHG15 and OS (C) (n=9502). Survival plots in the GEPIA cohort via merging the expression data of SNHG15 and DFS (D) (n=9502).